1. Home
  2. UIS vs ABEO Comparison

UIS vs ABEO Comparison

Compare UIS & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

HOLD

Current Price

$2.88

Market Cap

260.2M

Sector

Technology

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.22

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UIS
ABEO
Founded
1942
1974
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
260.2M
281.0M
IPO Year
N/A
1980

Fundamental Metrics

Financial Performance
Metric
UIS
ABEO
Price
$2.88
$5.22
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$5.88
$18.20
AVG Volume (30 Days)
672.3K
1.2M
Earning Date
02-17-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.29
Revenue
$1,921,000,000.00
$400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,589.77
P/E Ratio
N/A
$4.01
Revenue Growth
N/A
N/A
52 Week Low
$2.37
$3.93
52 Week High
$7.54
$7.54

Technical Indicators

Market Signals
Indicator
UIS
ABEO
Relative Strength Index (RSI) 53.62 51.80
Support Level $2.58 $5.07
Resistance Level $2.89 $5.40
Average True Range (ATR) 0.10 0.23
MACD 0.01 -0.02
Stochastic Oscillator 87.14 54.00

Price Performance

Historical Comparison
UIS
ABEO

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: